{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-060293","form_type":"8-K","ticker":"SGHT","cik":"0001531177","company_name":"Sight Sciences, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.400914+00:00","generated_at":"2026-06-08T14:56:55.629182+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sight Sciences Q3 revenue up 7% to $20.0M, withdraws FY 2023 guidance on LCD uncertainty","bullets":["Q3 revenue $20.0M (+7% YoY); Surgical Glaucoma $18.4M (+8% YoY); Dry Eye $1.6M (-1% YoY).","Net loss $13.0M ($0.27 per share) vs $22.2M ($0.46) a year ago; gross margin 86.6% (vs 84.3%).","Withdraws full-year 2023 revenue and adjusted operating expense guidance due to WPS LCD uncertainty.","Implements ~10% RIF expecting $7.9M annualized savings; other cost initiatives ~$5.0M annual savings.","Appointed Matt Link as Chief Commercial Officer; GEMINI 2 study shows sustained IOP reduction at 36 months."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-060293","json":"https://secwatch.observer/filing/0000950170-23-060293.json","markdown":"https://secwatch.observer/filing/0000950170-23-060293.md","text":"https://secwatch.observer/filing/0000950170-23-060293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531177/000095017023060293/0000950170-23-060293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531177/000095017023060293/sght-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T14:56:55.629182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"49578f4e1cd773c531b45f538cf1ec765406ecd9","claim":"Sight Sciences, Inc. reported third quarter ended September 30, 2023 results: revenue $20.0 million.","evidence_excerpt":"the third quarter ended September 30, 2023 and withdrew its guidance for full year 2023. Recent Business and Financial Highlights • Generated third quarter 2023 total revenue of $20.0 million, an increase of 7% compared to the same period in the prior year. • Achieved total gross margin of 86.6% in the third quarter of 2023 compared to 84.3% in the same period in the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531177/000095017023060293/0000950170-23-060293-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$20.0 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}